Announced Wed, 9 Apr · 15:12 IST

Information about successful completion of Inspection of JSTL Clinical and Bioanalytical facilities by CDSCO (Central Drugs Standard Control Organisation) under Regulation 30 of SEBI(LODR) ....

Regulatory Product ApprovalBusiness Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

CDSCO inspected Jeevan Scientific Technology's clinical facility at Balanagar and bioanalytical facility at Manikonda, Hyderabad, between April 1-8, 2025. The inspection was conducted to grant or renew registration of BA/BE (Bioavailability/Bioequivalence) study centres. The company confirmed the inspections were completed successfully with only minor observations, and inspectors found the organization compliant with all applicable regulations. Registration renewal/grant for both facilities is expected to be processed in due course.

Likely market impact

Positive for shareholders — successful CDSCO compliance means the company's core BA/BE study operations can continue without disruption, supporting ongoing and future business from pharmaceutical clients requiring these regulatory-approved facilities.